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Abstract
Background: The relation between therapeutic failure and non-adherence to treatment of malaria has been clearly
established. Several measures have been used to estimate adherence to Plasmodium vivax therapy, but few
protocols have been validated to ensure reliability of the estimates of adherence. The objective of this study was
to validate a five-item-reported-questionnaire derived from original Morisky four-item scale to estimate adherence
to P. vivax malaria therapy.
Methods: A five-item-reported questionnaire was applied to patients after treatment of P. vivax malaria, considering
behaviours regarding to forgetfulness, carelessness as to time of administration, cessation or discontinuation of
use and replication of dose. Data were collected in dichotomous and Likert scales. Reliability was assessed by
Cronbach’s alpha and by the contribution of each item to total. The concurrent validation was done with pill count
and concordance between measures of adherence by coefficient of Kappa. Sensitivity, specificity and accuracy were
also determined.
Results: A total of 135 patients were enrolled in the study. Adherence ranged from 63.8 to 72.7% in both
psychometric measures and pill count. The responses on the Likert scale showed higher proportion of non-
adherence behaviour, greater variance and concordance with pill count, as well as more sensitive to characterize
the behaviour of self-medication. The internal consistency of questionnaire was moderate. Significant correlations
were seen with items regarding the forgiveness or careless in taking pills in all scales. The agreement between
psychometric measures and pill count was considered satisfactory. The non-adherence to malaria therapy in an
endemic area of Amazon basin was 33.3%.
Conclusion: The five-item-reported questionnaire with responses on Likert scale is a feasible option for reliable
estimation of adherence to malaria therapy in endemic areas.
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Background
Malaria by Plasmodium vivax is a major health problem
in Amazon basin, with approximately 200,000 cases
reported annually [1]. The standard treatment is based on
the association of chloroquine plus primaquine according
to the recommendations of World Health Organization
[2]. However, treatment failure has been reported through-
out the world, including in Brazilian Amazon basin, where
it has been estimated at 10-15% [3-5]. Generally, it has
been associated both to resistance to anti-malarials
drugs and to decreased concentrations of drugs in the
bloodstream caused by incorrect dosage, poor drug
quality, drug interactions, variations in pharmaco-
kinetics parameters of drugs, and poor patient adherence
in respect of either dose or duration of treatment [6].
The treatment adherence ensures the complete reco-
very of patients and prevents the emergence of parasite
resistance [7]. There are several determining factors in
adherence to malaria therapy, such as perception of
disease, the complexity of the schedule, the quality of
prescription, or the patient’s clinical improvement [8].
The non-adherence to malaria therapy has been esti-
mated at 2-40%. A study in Brazilian Amazon basin
showed low adherence in 13.5% of patients [9]. * Correspondence: jvieira@ufpa.br
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such as pill count, use of electronic monitoring devices, pa-
tient’s interview before and after treatment about dose,
days and frequency, and measurement of the levels of
drugs or a metabolite in the bloodstream [10-14]. Methods
of self-reporting by the patient have been widely used, and
when properly structured and applied may provide a rea-
sonable accurate estimate of adherence [15]. Morisky et al.
[16] proposed a four-item-self-reported structured ques-
tionnaire on a sample of hypertensive patients to assess
medication adherence, considering that drugs errors or
omission could occur in any or all of several ways: for-
getting, carelessness, stopping the drug when feeling
better or starting the drug when feeling worse. Since
then, several improvements were made to increase the
reliability of Morisky questionnaire, as the addition of
new items, changes in response scales and concurrent
validation [17-22].
The direct relationship between therapeutic failure and
non-adherence with treatment has been clearly established
for several diseases, but few studies have evaluated the use
of psychometric measures for estimating adherence in
neglected diseases. The objective of this study was to val-
idate a five-item-self-reported questionnaire derived from
the original Morisky questionnaire, with the addition of
an item regarding self-medication behaviour, to be used to
estimate adherence to malaria therapy in endemic areas.
Responses were compared between dichotomous and
Likert Scales and pill count was used for concurrent
validation.
Methods
Study area
The study was carried from September to October 2012
at the Basic Unit Health at Anajas-PA, a rural munici-
pality at Marajo Island (0°59′21” S and 49°56′24” W),
with an area of 6.921 Km
2. The population was esti-
mated at 26,547 inhabitants in 2013. The transmission
of malaria is intense with some seasonal fluctuation.
Anajas reported in the last years the highest numbers of
cases of P. vivax in the state of Para.
Sample size
The sample size was determined using an expected non-
adherence proportion of 13%, with significance level 95%
and precision level of 5%. Therefore, the study would
require the participation of 135 patients with malaria by
P. vivax [23].
Patients and treatment
In this study were enrolled adults with slide-confirmed
infection by P. vivax. Exclusion criteria were: patients
with mixed malaria or with signs and symptoms of se-
vere malaria (jaundice, renal or pulmonary impairment,
severe anaemia, altered level of consciousness), parasite
density over 5%, glucose-6-phospate dehydrogenase de-
ficiency, and anti-malarials drugs treatment prior to in-
clusion in the study. Each subject received a multiple
oral doses of chloroquine (10 mg/kg on Day 0 and
7.5 mg/kg on days 1 and 2) co administered with prima-
quine (0.50 mg/kg/d for seven days, as 13.2 mg prima-
quine phosphate tablets) [2]. This study received approval
from the Institute Evandro Chagas Ethical Committee
(CEP/IEC/SVS/MS-0028/2010). All subjects provided
written consent before participation.
Data collection
Data were collected by two trained research assistants to
administer the structured five-item-self-reported ques-
tionnaire, the use of informed consent forms and the
procedures of questioning the participants [24]. The ori-
ginal Morisky questionnaire was translated to Portu-
guese by naive English spoken. Patients were monitored
daily in the community health center and those who
reached the seventh day of the medication were visited
at their homes to interview. The five-item-self-reported
questionnaire was completed by counting any remaining
pills, both of chloroquine and primaquine.
Measurements
Adherence was estimated using a five-item-self-reported
questionnaire derived from the four-item original of
Morisky. The five yes/no questions were: Do you ever
forget to take your pills? Are you ever careless in taking
your pills? Do you ever miss taking your pills when you
are feeling better? Do you ever miss taking any of your
pills because you are feeling sick? Do you replicate the
dose when you are feeling sick?
Initially, the patients were randomly allocated in two
groups; Group 01 (n =66), who answer questions in di-
chotomous scale (DS) as yes/no, in which a “no” answer
received a score of 1, and a “yes” answer received a score
of 0; and Group 02 (n =69), who answer questions on a
six point Likert scale (LS), as “all the time”, “nearly al-
ways”, “usually”, “sometimes”, “once a while” and “never”
[25]. Then the Likert scale was dichotomized (LDS) in
order to increase the sampling effort. The answers as “all
the time”, “nearly always”, “usually” and “sometimes”
were classified as yes (0) and “once a while” and “never”
classified as no (1). Finally LDS and DS were grouped
into an overall dichotomous scale (ODS), which was
correlated with pill count. Levels of adherence to anti-
malarial therapy in the LS were determined by the sum
of the percentage of each item divided by the total of the
item, and in the dichotomous scales by simply adding
each item. The values below the median were used to
allocate patients in the non-adherent group.
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consistency of questionnaire and by item-to-total, which
was used to determine the contribution of each item to
the overall reliability. Internal consistency was com-
pared between original Morisky and five-item-self-
reported questionnaires.
Pill count consists of a simply counting the number of
dosage units that the patient has not taken by the sche-
duled appointment. The returned dosage units are
counted and compared with the number of units received
by the patient. Medication regimen adherence is calcu-
lated by subtracting the number of units returned from
the number of units issued. The amount used is then
divided by the expected amount and multiplied by 100 to
determine the percentage of compliance. A full adherence
was considered when patients taken all pills (100%).
Patients taken above 70% were classified as “probably
adherent” and below 70% as “non-adherent”. If all pills
returned to the medical staff, the patients were considered
as “certainly non adherent”. Then the patients probably
adherent and with full adherence were classified as adhe-
rent, whereas the patients probably non-adherent and
certainly non-adherent as non-adherent.
Concordance between psychometric measures and pill
count was estimated by Kappa coefficient. Concurrent
validation of psychometric measures was done with pill
count followed by determination of sensitivity, specificity
and accuracy.
Statistical analysis
Data are presented as median and range. The Chi-square
was used to compare categorical variables. Reliability was
assessed by Cronbach’s alpha and by the contribution
of each item-to-total, determined by Spearman’sR a n k
correlation [26]. Cronbach’s alpha also was used to de-
termine the reliability of original Morisky and five-item-
self-reported questionnaires. The concurrent validation
between pill count and psychometric measures was
done by Spearman’s Rank correlation. The coefficient of
Kappa estimates the concordance between pill counts
with psychometric measures [27]. Distribution of prob-
abilities was used to determine the sensitivity, specificity
and accuracy of questionnaire. The analysis was per-
formed using SPSS 21.0 (SPSS Inc. Chicago Il). The sig-
nificance level accepted was 5%.
Results
A total of 135 patients were included in the study in age
from 18–52 years (mean 36 years). Sixty percent of the
patients were male (95%CI: 51.1-67.4). The descriptive
analysis of psychometric measures is show in Table 1.
Likert scale showed the highest variance.
Adherence behaviour ranged from 63.8 to 72.7%. There
were significant differences between adherent and non-
adherent groups, but the estimate in each group were
similar in all measures of adherence to treatment. The
higher proportion of non-adherence was seen in LS (95%
CI: 24.6-46.4) and the lower in DS (95%CI: 16.7-37.9)
(Table 2).
Cronbach’s alpha values ranged from 0.609 to 0.672
and 0.508 to 0.717 in the original Morisky and in the
five-item-self-reported questionnaires, respectively. The
internal consistency was moderate (>0.5), with high values
in LS in both questionnaires (Table 3).
The item-to-total correlation coefficient ranged from
−0.07 to 0.59 (DS), 0.26 to 0.72 (LS), 0.20 to 0.70 (LDS)
and 0.15 to 0.65 (ODS). Significant correlations were seen
with items regarding the forgiveness or careless in taking
pills (i-1 and i-2) in psychometric scales. A negative cor-
relation was seen with the fifth-item in DS. Only the LS
showed significant correlation after the introduction of the
fifth item. Cronbach’s alpha values decreased in psycho-
metric scales after excluding items i-1 and i-2, reducing the
reliability of measurements. The exclusion of item i-5
(self-medication behaviour) reduced Cronbach’sa l p h a
values of LS and LDS, confirming the usefulness of the LS
to characterize behaviour of self-medication (Table 4).
Table 2 Adherence and non-adherence to treatment estimated by psychometric measures and by pill count
Measure of adherence to
treatment
Non-adherence Adherence p-values
(%) 95%CI (%) 95%CI
Dichotomous (n= 66) 27.3 (16.7-37.9) 72.7 (60.6-81.8) <0.0001*
Likert (n = 69) 36.2 (24.6-46.4) 63.8 (52.2-72.5) 0.0078*
Likert dichotomized (n= 69) 34.8 (24.6-43.5) 65.2 (53.6-73.9) 0.0033*
Overall dichotomous (n=135) 31.1 (23.0-37.8) 68.9 (61.5-74.8) 0.0002*
Pill count (n=135) 28.9 (21.5-34.8) 71.1 (63.0-77.8) <0.0001*
*Statistically significant.
Table 1 Descriptive analysis of the total scales scores in
psychometrics measures
MMAS Median Range Variance
Dichotomous (n= 66) 0.6 0.26-0.88 0.063
Likert (n = 69) 4.68 3.84-5.12 0.280
Likert dichotomized (n= 69) 0.54 0.22-0.71 0.048
Overall dichotomous (n=135) 0.57 0.24-0.79 0.055
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pill count and psychometric measures ranged from 0.69
to 0.94, indicating a significant correlation between these
variables, with higher values in LS and LDS. In fact, a
strong correlation was seen between pill count and LS
(Table 5). There was a good agreement between data
from psychometric measures with pill count. Kappa
values ranged from 0.683 to 0.936, with the high value
in LS (Table 6).
Accuracy and the capacity of five-item-self reported,
to distinguish non-adherence in a group of non-adherent
patients, as well the adherence in a group of probably
adherent patients were high in psychometric measures
(Table 7). Again, the high values were observed in LS.
Finally, the application of five-item-self reported with
responses in LS to patients with malaria by P. vivax
indicates a non-adherence of 33.3% to malaria therapy.
The main reason to low adhesion in psychometric mea-
sures were the miss taking the pills when the patients
are feeling better or sick.
Discussion
The adherence to malarial therapy is a challenge in en-
demic areas of seasonal transmission, such as Amazonia
region, with several epidemiological characteristics asso-
ciated with environmental and behavioural variables of
human host, Plasmodium and mosquitoes [28,29]. Ma-
laria is an acute infectious disease with short treatment
period, but the complexity of dosing regimens and the
poverty in the region hamper the adherence with the-
rapy, leading to high levels of low adherence or even
non-adherence [30].
No single measure can be considered as gold standard
for all types of adherence studies. The uses of biomarkers
or the routine analysis of anti-malarials in biological media
is not feasible in several endemic areas, and the uses of
drug blood levels as a measure of adherence is compli-
cated by the potential pharmacokinetics variability of these
drugs. On other hand, self-report can be affected by
different biases, since the patient tends to give the ex-
pected answer. In fact, the methods of self-report
underestimate non-adherence, compared to pill count
or biological assays. However, when properly structured
and implemented self-report can provide valuable infor-
mation on the behaviour of adherence.
To improve the reliability of the five-item-self-reported
questionnaire the responses were compared among psy-
chometric scales. As expected, LS showed the highest vari-
ation in response, because the greatest number of response
options usually involves a greater variance and the infor-
mation supplied will be better the higher the variance of
the responses. The non-adherence to treatment was signifi-
cantly lower when measured by psychometric scales, and
by pill count. However, when the non-adherence was com-
pared among measures of adherence to treatment the re-
sults were similar, with the highest values on the LS,
corroborating the item response theory, in which the great-
est number and variability of scores increases the likeli-
hood of differentiating subjects, as well as high correlations
with the various items [31,32].
In this study the four-item-self reported originally pro-
posed by Morisky et al. was modified with the inclusion
of a fifth-item regarding self-medication, since a high
numbers of treatments are taken at home without
medical supervision. The inclusion of the fifth item did
not modify the internal consistency of the questionnaire
assessed by Cronbach’s alpha. The internal consistency
was considered moderate when assessed in dichotomous
Table 4 Reliability of five-item structured self-report in dichotomous and Likert scales
Parameters Scales Item
(i-1) (i-2) (i-3) (i-4) (i-5)
Item-to-total correlation Dichotomous 0.59 0.55 0.30 0.09 −0.07
Likert 0.72 0.58 0.38 0.26 0.51
Likert dichotomized 0.70 0.61 0.26 0.20 0.35
Overall dichotomous 0.65 0.58 0.28 0.15 0.18
Cronbach’s alpha when item was excluded Dichotomous (0.508)* 0.22 0.24 0.43 0.58 0.60
Likert (0.717)* 0.55 0.62 0.71 0.75 0.67
Likert dichotomized (0.657)* 0.46 0.50 0.66 0.7 0.63
Overall dichotomous (0.599)* 0.37 0.40 0.58 0.65 0.62
*Cronbach’s alpha original values.
Table 3 Internal consistency of original Morisky and five-
item-structured questionnaires
Measure of adherence to treatment Morisky Five-item
Dichotomous (n= 66) 0.609 0.508
Likert (n = 69) 0.672 0.717
Likert dichotomized (n= 69) 0.630 0.657
Overall dichotomous (n=135) 0.621 0.599
Cronbach’s alpha values.
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sion of the fifth item decreased the internal consistency of
LS and LDS, but increased in DS and ODS, indicating that
LS, even after dichotomizing to LDS, increases the reli-
ability of evaluating self-medication. The inclusion of the
fifth item also increased the coefficient of correlation only
on the LS.
The concordance between psychometric measures with
pill count to estimate both adherence and non-adherence
was high. Responses on LS showed a better concordance,
which was reduced after its dichotomization to LDS.
Dichotomous scales have several shortcomings when
compared to LS, because they generally fall in sensibility
and accuracy, and can generate false positive results
underestimating the non-adherence. As an example, in LS
a high frequency of answers “sometimes” in both items
that report the deliberate interruption of treatment, which
usually is not readily taken over by the patient, indicates
probably, cognitive imprecision and, the interpretation of
the answer “sometimes” on a dichotomous scale is highly
subjective. Corroborating this finding, LS also presented
higher values of sensitivity, specificity and accuracy when
compared to dichotomous scales.
Pill count can be a feasible alternative to shortcomings
of determining anti-malarials blood levels in endemic
areas and was used to concurrent validation. Correlations
of psychometric measures with pill count were considered
excellent, with higher value in LS [35]. The main require-
ments to psychometric measures methods are: avoid sim-
plistic dichotomies, be relatively inexpensive and easy to
use and analyse, provide reliable, and provide a continu-
ous record of compliance history. Thus, the results of this
study indicate that the psychometric measures using
structured questionnaires applied correctly are reliable for
estimating adherence to malaria therapy. Answers on LS
provide more valuables information on the behaviour of
uses of anti-malarials. When applied to patients with
P. vivax from Amazon basin, the five-item-self-reported
q u e s t i o n n a i r ew i t hr e s p o n s eo nL Se s t i m a t ean o n -
adherence of 33.3%, which corroborate previous reports
from others endemic areas [36,37]. The interruption of
treatment, both feel better or worse, was considered the
most important reason to non-adherence.
Conclusion
The five-item-self-reported questionnaire derived from the
original Morisky questionnaire, with the addition of an
item regarding self-medication behaviour with response on
Likert scale is a feasible option for reliable estimation of
adherence to malaria therapy in endemic areas.
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Table 6 Concordance of psychometric measures with pills
count
Scales Pill count (PC) Total Kappa
1
Non-
adherence
Adherence C.O
2
n (%) n (%) (%)
Dichotomous 0.683
Non-adherence 13 72.2 5 27.8 18 87.9
Adherence 3 6.3 45 93.8 48
Total 16 24.2 50 75.8 66
Likert 0.936
Non-adherence 23 92.0 2 8.0 25 97.1
Adherence 0 - 44 100.0 44
Total 23 33.3 46 66.7 69
Likert dichotomized 0.839
Non-adherence 21 87.5 3 12.5 24 92.7
Adherence 2 4.4 43 95.6 45
Total 23 33.3 46 66.7 69
Overall dichotomous 0.771
Non-adherence 34 81.0 8 19.0 42 90.4
Adherence 5 5.4 88 94.6 93
Total 39 28.9 96 71.1 135
1Values of Kappa according Rosner (2006).
2Concordance observed.
Table 7 Sensitivity, specificity and accuracy of
psychometric measures in several scales
Measure of adherence
to treatment
Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
Dichotomous (n= 66) 81.3 90.0 87.9
Likert (n = 69) 100 95.7 97.1
Likert dichotomized (n= 69) 91.3 93.5 92.8
Overall dichotomous (n=135) 87.2 91.7 90.4
Table 5 Concurrent validation between pill count and
psychometric measures in several scales
Measure of
adherence
to treatment
Dichotomous Likert Likert
dichotomized
Overall
dichotomous
Dichotomous
(n= 66)
--- -
Likert (n = 69) −0.01 - - -
Likert
dichotomized
(n= 69)
−0.09 0.90* - -
Overall
dichotomous
(n= 135)
−0.10 0.43* 0.47* -
Pill count
(n= 135)
0.69* 0.94* 0.84* 0.77*
*Statistically significant.
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